LATEST NEWS
News Releases
![news icon](/wp-content/uploads/2023/10/news-icon.jpg)
16 May 2024
NanoCell Therapeutics Inc. and OneChain Immunotherapeutics S.L Announce Collaboration on In Vivo CAR-T Therapy for B-cell Lymphoma
![news icon](/wp-content/uploads/2023/10/news-icon.jpg)
19 March 2024
NanoCell Therapeutics Inc. Appoints Charles F. Albright, PhD, to its Scientific Advisory Board
![news icon](/wp-content/uploads/2023/10/news-icon.jpg)
26 September 2023
NanoCell Therapeutics Inc. Appoints Dr. Jacek Lubelski, PhD as Chief Technology Officer
![news icon](/wp-content/uploads/2023/10/news-icon.jpg)
3 August 2023
NanoCell Therapeutics Inc. Appoints Florence Salmon, PhD to its Scientific Advisory Board
![news icon](/wp-content/uploads/2023/10/news-icon.jpg)
4 January 2023
NanoCell Theapeutics Inc, in Consortium with Leading Research Organizations, Secures Multimillion Euro HORIZON-EIC Pathfinder Challenges Grant for Pioneering Gene Therapy Platform